|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.40 - 1.47|
|52 Week Range||1.28 - 6.15|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Biotech stocks staged a recovery this week, thanks to a deal in the space and news concerning positive pipeline developments. The iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) gained 4.26 percent ...
I am going to take a deep dive into Cyclacel Pharmaceuticals Inc’s (NASDAQ:CYCC) most recent ownership structure, not a frequent subject of discussion among individual investors. When it comes toRead More...
When Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) released its most recent earnings update (30 September 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...
The direct benefit for Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-offRead More...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cyclacel Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to CYCC-US. Comparing the performance and risk of Cyclacel Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Below is a list of notable corporate events for the week beginning October 16. Note, this list is not comprehensive and all dates are subject to change. Monday Earnings Netflix, Inc (NASDAQ: NFLX ) Q3 ...